FHLC offers broader sector exposure at a 0.08% expense ratio, compared with IBB's concentrated biotech focus at 0.44%, but IBB delivered stronger 1-year returns despite higher volatility.
Fidelity MSCI Health Care Index ETF (FHLC) News
Latest headlines that mention FHLC, newest first · each headline opens the original publisher
- Last price
- $85.91
- Day change
- -0.45%
- Next earnings
- —
FHLC headlines
latest coverageNot much coverage yet. FHLC has appeared in only a few headlines lately; new stories show up here as publishers cover it.
VanEck's concentrated 25-stock biotech portfolio surged 40.5% in one year, but Fidelity's diversified 365-holding fund delivered superior risk-adjusted returns with half the volatility.
Compare global reach to domestic focus as these two funds reveal key differences in cost, risk, and portfolio makeup for healthcare investors.
Also mentioned with FHLC
30d
Headlines that tag both tickers
FHLC news alerts
Get an alert by email or push when a new headline mentions FHLC.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.